Table 5 Associations between polymorphisms and overall haematological, gastrointestinal and neurological toxicity
From: Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
Haematological | Gastrointestinal | Neurological | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0–2 | 3–4 | 0–2 | 3–4 | 0–2 | 3–4 | ||||||||||
Genotype | n | % | n | % | P | n | % | n | % | P | n | % | n | % | P |
MTHFR 677 | |||||||||||||||
CC | 24 | 56 | 19 | 44 | 37 | 86 | 6 | 14 | 33 | 77 | 10 | 23 | |||
CT | 40 | 74 | 14 | 26 | 50 | 93 | 4 | 7 | 49 | 91 | 5 | 9 | |||
TT | 12 | 63 | 7 | 37 | 0.17 | 14 | 74 | 5 | 26 | 0.10 | 14 | 74 | 5 | 26 | 0.10 |
ERCC1–118 | |||||||||||||||
CC | 7 | 70 | 3 | 30 | 10 | 100 | 0 | 0 | 9 | 90 | 1 | 10 | |||
CT | 43 | 67 | 21 | 33 | 56 | 88 | 8 | 12 | 55 | 86 | 9 | 14 | |||
TT | 25 | 61 | 16 | 39 | 0.77 | 35 | 85 | 6 | 15 | 0.44 | 33 | 81 | 8 | 19 | 0.66 |
XRCC1–399 | |||||||||||||||
GG | 9 | 60 | 6 | 40 | 13 | 87 | 2 | 13 | 15 | 100 | 0 | 0 | |||
AG | 41 | 67 | 20 | 33 | 53 | 87 | 8 | 13 | 49 | 80 | 12 | 20 | |||
AA | 25 | 64 | 14 | 36 | 0.86 | 35 | 90 | 4 | 10 | 0.90 | 33 | 85 | 6 | 15 | 0.17 |